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Abstract
Alcohol has been consumed by most societies over the last 7000 years. Abraham Lincoln
said “It has long been recognized that the problems with alcohol relate not to the use of a
bad thing, but to the abuse of a good thing.” Light to moderate alcohol consumption
reduces the incidence of coronary heart disease (CHD), ischemic stroke, peripheral
arterial disease, CHD mortality, and all-cause mortality, especially in the western
populations. However, heavy alcohol consumption is detrimental causing
cardiomyopathy, cardiac arrhythmias, hepatic cirrhosis, pancreatitis, and hemorrhagic
stroke. In this article, we review the effects of alcohol on CHD, individual cardiovascular
risk factors, cardiomyopathy, and cardiac arrhythmias, including the most recent
evidence of the effects of alcohol on CHD.

Alcohol and Global Burden of Disease
An estimated 3·8% of all global deaths are attributable to the detrimental effects of
alcohol consumption.[1] Disease burden and disability are closely related to the volume
of alcohol consumption.[1] Alcohol dependence is a major health and social issue
affecting 4 to 5% of the United States population at any given time,[2] with a lifetime
prevalence of 12.5%.[3] In the United States, approximately 30% of those who drink
alcohol do so excessively. Excessive drinking is the third leading preventable cause of
death, accounting for 79,000 deaths annually, and resulting in approximately 2.4 million
years of potential life lost.[4, 5] Heavy drinkers (> 6 drinks) had a doubled mortality rate,
and consumption of 3 to 5 drinks was associated with a 50% higher mortality rate.[6]

However, moderate alcohol consumption is protective against CHD,[7] with higher
cardiovascular event rates occurring among abstainers and heavy drinkers. There is a
plethora of epidemiological evidence, demonstrating a J- or U-shaped association
between alcohol consumption and all-cause mortality (Figure 1),[8] as well as
cardiovascular morbidity and mortality (Figure 2).[9] However, this hypothesis was
challenged by a meta-analysis that showed a lack of benefit of alcohol in preventing
CHD.[10] In addition, ethnicity, gender, type of alcoholic beverage, and pattern of
alcohol intake, may also influence the relation between alcohol and CHD.

Epidemiological Studies Showing a Favorable Effect of Alcohol on the
Heart
Ethanol consumption showed a strong U-shaped relationship with CHD mortality for
male nonsmokers, and heavy smokers, irrespective of beverage type, and for female
smokers, after a 24-year follow-up. In nonsmokers, beer and wine were associated with
greater reductions in CHD mortality than spirits.[11] Light and moderate alcohol
consumption were inversely associated with cardiovascular mortality over a 25 year
period, even when compared with lifetime abstainers.[12]

In a pooled analysis of 8 prospective studies from North America and Europe, including
192,067 women and 74,919 men free of cardiovascular diseases and diabetes, there was
an inverse association between alcohol and risk of CHD in all age groups.[13] In the
Health Professionals Follow-up Study, moderate alcohol intake was associated with
lower risk for myocardial infarction (MI) in men free of major illness, during 16 years of

follow-up of 8867 physicians.[14] A prospective cohort study of 64,597 Chinese men
aged > 40 years, who were free of clinical CHD, showed alcohol consumption was
associated with a lower risk of MI and CHD after 494,084 person-years follow-up.[15]
Maintaining alcohol consumption below 46g/day in men and 23g/day in women appears
to minimize the risks of mortality in a Japanese population, based on a pooled analysis of
six ongoing large-scale cohort studies (n = 309,082). There was a J- or U-shaped
association for the risk of total and major causes of mortality in men, and the risk of total
and heart disease mortality in women.[16] A J-shaped relation between alcohol
consumption and incident cardiovascular disease (CVD), and total and CVD deaths was
found during a mean follow up of 12.2 years in 26,399 women.[17] Compared with
abstainers, alcohol intake of 5 to 14.9 g/d was associated with 26%, 35%, and 51% lower
risk of CVD events, total death, and CVD death, respectively, in a multivariable
model.[17] In a Japanese study of 34,776 men and 48,906 women aged 40 to 79 years,
followed-up for a median duration of 14.2 years, heavy alcohol consumption was
associated with increased CVD mortality in men, and CHD in women, whereas light-tomoderate drinking was associated with reduced CVD mortality in both sexes.[18]

In the Nurses’ Health study of 87,526 female nurses aged 34 to 59 years, moderate
alcohol consumption decreased the risks of CHD during 334,382 person-years of followup, compared with nondrinkers.[7] In the Women's Health Initiative (WHI) comprising
10,576 black and 105,610 white postmenopausal women free of cardiovascular disease,
moderate drinking was associated with a lower risk of total mortality among Caucasian
women during a mean follow-up of 8 years, regardless of hypertensive status, but only in

hypertensive African-American women.[19] In the Swedish Women's Lifestyle and
Health Study of 47,921 women aged 30-49 years, a significant inverse association was
found between light to moderate drinking and total mortality. This was predominantly
driven by reduction in cardiovascular mortality, during 713,295 person-years followup.[20] In the Women's Health Initiative Observational Study, during the 22,546 personyears of follow-up, both frequency and quantity of alcohol intake were inversely
associated with the risk of developing CHD, irrespective of the beverage type.[21]
Moderate alcohol consumption in postmenopausal women may have a benefit on CHD,
irrespective of their diabetic status.[21] In the Nurses' Health Study, moderate alcohol
consumption was associated with reduced CHD risk in women with diabetes, during
39,092 person-years of follow-up.[22] Moderate alcohol consumption was protective
against coronary atherosclerosis progression demonstrated by quantitative coronary
angiography in the Stockholm Female Coronary Risk Angiographic Study.[23]

Moderate alcohol consumption also reduces mortality in patients with documented CVD.
Light to moderate alcohol consumption (5 to 25 g/day) was associated with a lower
incidence of CVD events and all-cause mortality in a recent meta-analysis of 8
prospective studies including 16,351 subjects with history of CVD. J-shaped pooled
curves were observed with both CVD and all-cause mortality.[9] In patients with
clinically manifest vascular disease or diabetes (n = 5447) from the Second
Manifestations of Arterial Disease (SMART) study, moderate alcohol consumption (1–2
drinks/day) was not only associated with a reduced risk of vascular and all-cause death,
but also with reduced risks of non-fatal events from CHD, stroke and amputations.[24] In

the Prospective Epidemiological Study of Myocardial Infarction (PRIME), in Northern
Ireland and France, regular and moderate alcohol intake was associated with a low risk of
CHD, whereas the binge drinking pattern conferred a higher risk.[25] Only wine drinking
was associated with a lower risk of hard coronary events.[25] Moderate alcohol intake
was inversely associated with CHD in hypertensive men in the Physicians' Health Study,
and Health Professionals Follow-Up Study, after 26- and 16-year follow-ups,
respectively.[26, 27]

Moderate alcohol consumption in the year prior to acute MI was associated with reduced
total and CV mortality following infarction, irrespective of gender and beverage type,[28]
and a significant reduction in cardiovascular complications in survivors of acute MI.[29]
In the Stockholm Heart Epidemiology Program (SHEEP) study, moderate alcohol
drinking was beneficial following acute MI, after a median follow up of 8 years.[30] In
the Optimal Trial in Myocardial Infarction with the Angiotensin II Antagonist Losartan
(OPTIMAAL) trial, there was a strong positive association between moderate alcohol use
and survival in patients with heart failure and/or evidence of left ventricular dysfunction
following MI.[31] Persistent moderate alcohol drinking following an acute MI was
associated with a trend toward less angina, fewer re-hospitalizations, lower 3-year
mortality, and better disease-specific quality of life, and mental health than quitters.[32]
In the Post-CABG trial, inverse trends were observed between moderate drinking and
morbidity as well as graft disease progression.[33]

Epidemiological Studies Showing Neutral Results of Alcohol on the
Heart

While a great many studies have shown favorable effects on CHD and all-cause mortality
with light to moderate alcohol intake (Table 1), some studies have shown a neutral effect,
and heavy alcohol consumption was shown to be detrimental. In the Framingham Study,
cumulative incidence of alcohol use disorders did not show a decrease despite a decrease
in average alcohol intake and more wine consumption after more than 50 years of followup.[34] Contrary to the cardioprotective effect of moderate regular alcohol consumption,
heavy, episodic drinking was related to higher risk of CHD,[35] and indeed in a
prospective study of patients with MI, although moderate alcohol intake was associated
with lower mortality, binge drinking, even among light drinkers, was associated with 2fold higher mortality.[36] A meta-analysis of 14 studies showed the cardioprotective
effect of moderate alcohol consumption disappears when, on average, light to moderate
drinking was mixed with irregular heavy drinking (>60 g of pure alcohol or > or =5
drinks per occasion at least monthly).[37] Former drinkers compared to long-term
abstainers had significantly increased risk for CHD mortality, in a recent metaanalysis.[38] In a meta-analysis of six studies, a J-shaped curve, with nadir of
approximately 28 grams of alcohol (2 drinks) per week, was observed including drinkers
who consumed alcohol for 2 days a week or less. Conversely, in people who consumed
alcohol for more than 2 days a week, a significant protective effect was seen even when
drinking high amounts of alcohol.[39] In a meta-analysis of 28 cohort studies, there was a
20% relative risk reduction in CHD for up to 20 g/day of alcohol consumption, and
evidence of a protective effect up to 72 g/day, but increased risk above > 89 g/day.[40]

The beneficial effects of light to moderate alcohol consumption on CHD could not be
replicated in some studies, especially in studies of certain ethnic populations. Table 2 lists
studies showing no favorable effects of light to moderate alcohol consumption on
cardiovascular or all-cause mortality. In the NHANES Epidemiologic Follow-Up Study
(NHEFS), no J-shaped beneficial relationship was found between alcohol consumption
and mortality in African Americans. Conversely, mortality increased with increasing
consumption of more than one drink a day in both genders.[41] Risk for all-cause
mortality was similar for non-drinkers and men drinking up to 14 units per week (1 unit
was equivalent to one measure of spirits, half a pint of beer, or one sixth bottle of wine)
in Scottish men followed-up for 21 years, with an unfavorable outcome for drinking over
22 units a week.[42] In Asian-Indian men, no protective association was found between
alcohol intake and prevalence of CHD. In fact, alcohol intake was associated with a
higher odds ratio for CHD risk.[43, 44] Moderate-to-heavy alcohol consumption not only
showed lack of benefit on CHD mortality in older Chinese men,[45] but also increased
the risk of angiographically proven CAD.[46] In the Lipid Research Clinics Prevalence
and Follow-up Studies, no difference in mortality rates were found between drinkers and
non-drinkers in Russia.[47] In a cohort of males of high socioeconomic status, moderate
alcohol consumption had no net benefit compared with abstinence, and > 3 drinks per day
was associated with worse quality of life, and adversely affected mortality after a 29-year
follow-up.[48]

In a population based prospective study of 7169 men aged 45-64 years followed for a
mean of 12.8 years, compared to occasional drinking, regular light alcohol consumption

(1-14 units per week) in men with established CHD was not associated with any
significant benefit, or all cause mortality. Higher levels of intake (>/= 3 drinks per day)
were associated with increased mortality in men with previous MI.[49] In the MultiEthnic Study of Atherosclerosis (MESA) study, heavy consumption of hard liquor was
associated with greater coronary artery calcium accumulation and there was no evidence
of a protective or J-shaped association of alcohol and coronary artery calcium over a 2- to
4-y period.[50] Alcohol consumption was directly associated with carotid intima-media
thickness in young healthy adults, independent of cardiovascular risk factors, suggesting
a pro-atherogenic effect.[51]

Lack of replication of the well documented protective effect of moderate alcohol use in
some studies could suggest that the protective effect of alcohol on CHD does not extend
to all populations or that the confounding factors may not have been completely
accounted for. Moreover, self reporting of alcohol consumption may have been less
accurate rather than actual consumption. Other factors that may have contributed to the
neutral effects of alcohol consumption include differences in the ethanol content, serving
size, pattern of consumption, and phenotypic differences in the metabolism of alcohol. A
meta-analysis of 54 all-cause mortality studies and 35 CHD mortality studies,[10]
highlighted systemic,[52] and misclassification errors from the epidemiological studies,
that demonstrated a J- or U-shaped benefit with alcohol consumption. However, this
study was limited by the exclusion of some major studies which showed positive effects
of alcohol on CHD. Another recent large systematic review and meta-analysis addressed

this issue, and inclusion of former drinkers did not seem to bias the beneficial association
of alcohol consumption with cardiovascular disease.[53]

Alcohol Consumption and Vascular Disease
Light to moderate alcohol consumption decreases risk of ischemic stroke, but heavy
alcohol consumption may increase the risk of total stroke.[7, 54, 55] Moderate alcohol
consumption also decreases risk of peripheral arterial disease.[56-59]

Alcohol and Cardiovascular Risk Factors
Moderate alcohol consumption has been associated with lower CHD risk in numerous,
but not all, epidemiological studies. Alcohol reduces many but not all of the risk factors
for CHD. The 2003 Behavioral Risk Factor Surveillance System data showed, while 27
of the 30 CHD-associated factors were significantly more prevalent in nondrinkers,
compared to moderate drinkers, after adjusting for age and gender, few (if any) of these
differences were likely due to alcohol consumption itself.[60] There was a J- or U-shaped
relationship between alcohol intake and the prevalence of multiple cardiovascular risk
factors, amongst non-smokers and smokers, in 27,005 middle aged Japanese men.[61] In
the Italian Longitudinal Study on Aging (ILSA), moderate alcohol consumption at older
age was associated with healthier hematological values of fibrinogen, HDL cholesterol
(HDL-C), apo A-I lipoprotein and insulin. But it was also associated with a worse
hematological picture of total cholesterol, LDL cholesterol (LDL-C) levels, and systolic
blood pressure.[62]

Alcohol and Lipids

CHD risk reduction in light to moderate alcohol drinkers is generally attributed to a
beneficial effect on HDL-C levels. However, this hypothesis was disputed recently in
a large, population based Norwegian cohort (CONOR) study with extensive control
for confounding factors.[63] Alcohol intake increases HDL-C in a dose-dependent
fashion up to 18%, associated with and possibly caused by an increase in the
transportation rates of HDL apolipoproteins apoA-I and A-II.[64] HDL-C and apoA-I
levels were significantly elevated in the Atherosclerosis Risk in Communities (ARIC)
study, irrespective of the quantity or type of beverage consumed.[65] In a meta-analysis
of 42 studies, 30 g of ethanol a day increased concentrations of HDL-C by approximately
4 mg/dl, and apoA-I by 8.82 mg/dl, with an estimated risk reduction of 24.7% in
CHD.[66] In a recent systematic review and meta-analysis of 44 studies, alcohol
significantly increased levels of HDL-C, apoA1, and adiponectin. Alcohol showed a
dose-response relation with HDL-C, decreased fibrinogen levels, and did not affect
triglyceride levels.[67]

Incremental alcohol intake was associated with significantly elevated levels of HDL-C,
phospholipid enrichment of HDL, and a shift from HDL 3 subfraction to HDL 2, all of
which, may augment the antiatherogenic effect of HDL-C.[68] Cholesterol efflux from
macrophages to HDL (2) particles was significantly increased by heavy alcohol
consumption, with associated decrease in cholesteryl ester transfer protein (CETP)
activity, and increased phospholipid transfer protein (PLTP) activity.[69] Moderate
alcohol consumption increased cholesterol efflux, possibly mediated by ATP-binding
cassette transporter (ABCA1) in healthy men,[70] and in postmenopausal women.[71]

Serum non-HDL cholesterol is a strong predictor of cardiovascular diseases. Even light
drinking significantly lowered serum non-HDL cholesterol in healthy adults, with the
effect more pronounced in women.[72] In the Cardiovascular Health Study, alcohol
intake was associated with less total LDL particles, lower levels of small LDL, HDL, and
very-low-density lipoprotein particles, and higher levels of large LDL and medium- and
large-sized HDL particles, as measured by nuclear magnetic resonance (NMR)
spectroscopy.[73]

Genetic polymorphisms and their interaction with alcohol consumption have been
implicated in modulating serum lipid levels. Genetic variation in alcohol dehydrogenase
1C (ADH1C) and ADH3 have higher HDL levels and a substantially decreased risk of
CHD in moderate drinkers,[74, 75] but this finding could not be replicated in the British
Women's Heart and Health Study and Caerphilly cohorts.[76] Apolipoprotein E (APOE)
polymorphism and its interaction with alcohol, altered LDL-C levels in the Framingham
Offspring Study,[77] and in the Spanish EPIC cohort study.[78] Data from the Cohorte
Lausannoise (CoLaus) study suggests that the effect of alcohol consumption on HDL-C
levels may not be mediated by polymorphisms in APOA5, CETP, LIPC or LPL
genes.[79]

Alcohol and Diabetes Mellitus
Light to moderate alcohol consumption was inversely associated with type 2 diabetes in
4,655 elderly people in the Cardiovascular Health Study,[80] 2,879 healthy adults in the

Framingham Offspring Study,[81] and 20,951 physicians in the Physicians' Health Study
after a median follow up of 12.1 years.[82] In a systematic review and meta-analysis
comprising of 20 cohort studies, moderate alcohol consumption appeared protective for
type 2 diabetes with a U-shaped relationship in both sexes.[83] Moderate alcohol
consumption improved insulin sensitivity in relatively insulin-resistant middle-aged men,
an effect that may be mediated through alcohol-induced increases in adiponectin.[84] In a
nested case-control study, the inverse association between alcohol consumption and risk
of type 2 diabetes was not explained by circulating biomarkers of inflammation,
endothelial dysfunction, and fasting insulin, but adiponectin appeared to be a
mediator.[85]

Light to moderate alcohol consumption was associated with lower risk of CHD in men
with type 2 diabetes in the Health Professionals' Follow-up study (HPFS),[86] as well as
in the Physicians' Health Study,[87] and decreased risk of death due to CHD.[88] In a
meta-analysis of six cohort studies, moderate alcohol consumption was associated with a
lower risk of total mortality and any alcohol consumption was associated with lower risk
of CHD in type 2 diabetic populations.[89]

Alcohol consumption was also associated with a lower prevalence of metabolic syndrome
in the NHLBI Family Heart Study, irrespective of the type of beverage consumed,[90]
and in European population cohorts.[56, 91, 92] In a meta-analysis of 7 studies, alcohol
consumption of less than 40 g/day in men and 20 g/day in women significantly reduced
the prevalence of metabolic syndrome.[93]

Alcohol and Hypertension
Existing evidence is conflicting regarding the relation between alcohol consumption and
systemic hypertension.

In a systematic review and meta-analysis comprising 12 cohort studies from the United
States, Japan and Korea, the risk for hypertension increased linearly with alcohol
consumption. Among women, a significant protective effect was reported for
consumption at or below about 5 g per day. Among men, Asian populations had higher
risks than non-Asian populations of hypertension associated with alcohol intake.[94] In
the Coronary Artery Risk Development in Young Adults Study, 20-year follow up
showed no association between alcohol consumption and incident hypertension, except
among European-American women in whom any current alcohol consumption was
associated with lower risk of incident hypertension.[95] In the ARIC study participants,
the consumption of alcohol in amounts > 210 g per week was an independent risk factor
for hypertension in North America, after 6 years of follow-up. Light to moderate alcohol
consumption also appeared to be associated with a higher risk of hypertension in black
men.[96]

Light-to-moderate alcohol consumption decreased hypertension risk in women and
increased risk in men, after prospective follow-ups of 10.9 and 21.8 years, in the
Women's Health Study and Physicians' Health Study, respectively. The threshold above
which alcohol became deleterious for hypertension risk emerged at > 4 drinks per day in
women versus a moderate level of > 1 drink per day in men.[97] In Spanish men and

women, consumption of beer or spirits, but not wine, was associated with a higher risk of
developing hypertension, during a median follow-up of 4.2 years, irrespective of the
pattern of consumption.[98]

The mechanisms that lead to alcohol-induced hypertension have not been well defined.
In a study of healthy volunteers, higher blood pressure in drinkers, was not explained by
increased activity of the sympatho-adrenal and renal-pressor mechanisms.[99] Light-tomoderate alcohol intake appeared to have a possible vasculoprotective effect, as
measured by pulse wave velocity in subjects with optimal or normal blood pressure,
while heavy drinking caused a detrimental effect on the vasculature.[100] Increased
aortic pulse wave velocity was closely associated with alcohol consumption in middleaged Japanese men.[101]

Polymorphisms of alcohol-metabolizing enzymes (alcohol dehydrogenase (ADH) 2 and
aldehyde dehydrogenase (ALDH) 2 may influence alcohol metabolism. One such
polymorphism, ADH2(1)/2(1) genotype, was associated with lower levels of systolic
blood pressure.[102] Genotypic variations in Catechol- O-methyltransferase (COMT)
mRNA and the consequent genetically determined inactivation of catecholamines, may
influence alcohol-induced blood pressure elevation.[103]

Alcohol and Coagulation
Epidemiological studies indicate that consumption of alcohol at the average level of
intake in France (20-30 g per day) reduced risk of CHD by at least 40%, despite a high

intake of saturated fat. This “French Paradox,” may be attributable to regular wine
consumption. Alcohol is believed to protect from CHD by preventing atherosclerosis
through action on HDL-C, but serum concentrations were no higher in France than in
other countries. The effect of wine in lowering the platelet reactivity, as seen in France
compared to Scotland, may be one explanation for this protection.[104]

In the Framingham Offspring Study, light-to-moderate alcohol consumption was
associated with lower levels of coagulatory factors (fibrinogen, plasma viscosity, von
Willebrand factor, and factor VII), but higher intake was associated with impaired
fibrinolytic potential, reflected by higher levels of plasminogen activator inhibitor
antigen-1 and tissue plasminogen activator antigen. These findings are consistent with the
hypothesis that a balance between hemostatic and fibrinolytic activity may contribute to
the complex relation of alcohol use with coronary heart disease.[105, 106]

A dose-dependent effect of alcohol on decreased platelet aggregation was also seen in the
Caerphilly Prospective Heart Disease Study.[107] In a meta-analysis of 42 studies, 30 g
of daily alcohol consumption modestly increased concentrations of several haemostatic
factors including fibrinogen.[66] Wine drinkers had lower levels of plasminogen
activator inhibitor (PAI) antigen-1, and ADP-mediated platelet activation and aggregation
compared to others.[66]

Moderate alcohol intake was positively associated with plasma level of endogenous t-PA,
independent of HDL-C in the Physicians' Health Study.[108] In the NHLBI Family Heart

Study, alcohol consumption > 15g/d was associated with increased PAI-1.[109] These
findings support the hypothesis that changes in fibrinolytic potential may be an important
mechanism whereby moderate alcohol consumption decreases risk of heart disease.
Moderate alcohol consumption also improved endothelial function as evidenced by better
flow-mediated dilation (FMD) in the Northern Manhattan Study (NOMAS).[110]

Alcohol and Inflammation
In view of the robust association between markers of inflammation, especially C-reactive
protein (CRP), and risk of CHD, an anti-inflammatory action of alcohol could contribute
to the link between moderate consumption and lower cardiovascular mortality.
Multiple studies have demonstrated the beneficial effects of moderate alcohol
consumption on various inflammatory markers with significantly decreased levels of
plasma CRP, fibrinogen, interleukin-6 (IL-6), interleukin-1alpha, as well as plasma
viscosity, WBC count, factor VIIIc, and monocyte and endothelial adhesion
molecules.[111-115] Men who consumed 1-2 drinks/day had 26% lower CRP, and 36%
lower IL-6 levels, with a stronger association in women.[116] Lower CRP concentrations
were also observed in the Pravastatin Inflammation/CRP Evaluation Study, independent
of alcohol-related effects on lipids.[117] These results suggest an additional biological
explanation to the epidemiological link between moderate alcohol consumption and
decreased cardiovascular events.

Alcohol Preconditioning
Epidemiological data suggest that those who are regularly consuming alcohol prior to an
acute MI are more likely to survive, suggesting a preconditioning effect of alcohol.[28,

118] Ischemic preconditioning (IPC) is the most potent form of endogenous myocardial
protection against irreversible ischemia-reperfusion injury. In an animal models, longterm alcohol consumption reduced myocardial ischemia-reperfusion injury possibly
through repeated myocyte adenosine receptor activation,[119] and sustained translocation
of epsilon protein kinase C (εPKC).[120] In situ studies in rabbit showed, ethanol
exposure followed by washout or sufficient time to metabolize the alcohol prior to
ischemia, induces preconditioning-like myocardial protection.[121] Protection afforded
against ischemia and reperfusion injury (I/R) proceeds through an ischemic
preconditioning-like mechanism involving the activation of εPKC that is dependent on
the time and duration of ethanol treatment.[122, 123]

Of note, moderate dose of ethanol when taken acutely, abolished ischemic
preconditioning (IPC) occurring during sequential episodes of myocardial ischemia, and
is associated with worsening ischemia in a randomized prospective study in
humans.[124]

Wine versus other Alcoholic Beverages
Some but not all, epidemiological studies suggest that wine confers greater protection
against CHD than beer or distilled spirits, by virtue of its polyphenol content.[125] In a
systematic review and meta-analysis, small doses (1-4 drinks/day) of wine, beer, and
spirits were equally beneficial in reducing CHD.[126] Another systematic review that
included ecological, case-control, and prospective cohort studies, also showed that all
types of alcoholic drinks were linked with lower risk of CHD.[127] However, in a metaanalysis, relative risk of vascular disease associated with wine intake was 0.68 (95%
confidence interval, 0.59 to 0.77) in 209 418 persons compared to non-drinkers, with a
strong J-shaped relationship between different amounts of wine intake and vascular risk.

A similar but smaller association was also apparent with beer consumption, but no
meaningful relationship could be found between different amounts of beer intake and
vascular risk.[128] Potential protective mechanisms beyond the effects of ethanol
include, greater anti-oxidant effects,[129-131] decreased erythrocyte superoxide
dismutase activity,[132] and in vitro studies showing reduced vascular smooth muscle
cells proliferation,[133] vasorelaxation of human coronary arteries,[134] inhibition of
endothelin-1 synthesis,[135] and down-regulation of tissue factor (TF) gene
transcription.[136]

Alcohol and Heart Failure
Moderate alcohol consumption was associated with a lower risk of incident heart failure
among older adults and in the Physicians’ Health Study, independent of a number of
confounding factors. Further, it did not appear to be mediated by a reduction in MI risk,
after an extended follow-up of 18 years.[137-139] Light to moderate drinking was
associated with a lower risk of HF in hypertensive male physicians.[140] In the
Framingham Heart Study, during 26,035 person-years of follow-up in men, and 35,563
person-years of follow-up in women, alcohol consumption was not associated with
increased risk for heart failure, even among heavy drinkers (> 15 drinks/wk in men and >
8 drinks/wk in women). To the contrary, moderate alcohol consumption protected against
heart failure.[141] In a meta-analysis of 6 studies, infrequent and light-to-moderate
drinking was associated with a 10% to 20% lower risk of heart failure.[142] Heavy
alcohol drinking was associated with increased risk of non-ischemic cardiomyopathy, and

the apparent protection of alcohol against ischemic cardiomyopathy, supported its
protective effect against CHD.[143]
Alcohol is toxic to striated muscle in a dose-dependent manner, and in patients with
alcoholic cardiomyopathy, total lifetime dose of ethanol correlated inversely with the
ejection fraction and directly with the left ventricular mass.[144] In the Framingham
Offspring Study, alcohol intake was positively and independently associated with left
ventricular mass in men but not in women.[145] Subtle signs of cardiac abnormalities
such as left ventricular dilation with preserved ejection fraction and impaired left
ventricular relaxation may precede severe cardiac dysfunction in chronic asymptomatic
alcoholics.[146]
Changes in myocardial contractility due to chronic alcohol exposure do not result from
altered Ca2+ handling but from changes at the level of the myofilament that do not
involve myosin heavy chain isoform shifts.[147] Transgenic overexpression of insulinlike growth factor 1 attenuated the deleterious effects caused by chronic alcohol intake
such as interstitial fibrosis, reduced mitochondrial number, compromised cardiac
contractile function and intracellular Ca(2+) handling, decreased superoxide dismutase
(SOD) 1 expression, elevated superoxide production, and overt apoptosis, with the
exception of cardiac hypertrophy.[148]
Abstinence is the most critical step in halting further deterioration of cardiac contractility
in alcoholics. In a 4-year prospective cohort study in Spain, left ventricular ejection
fraction improved in both abstinent patients and those who controlled their drinking up to
60 grams of ethanol per day.[149]

Like the relationship between alcohol and CHD, the relationship between alcohol and
CHF is complex. While light to moderate alcohol intake may be protective, heavy
consumption increases heart failure risk.

Alcohol and Atrial Fibrillation
Moderate alcohol consumption was not significantly associated with a risk of atrial
fibrillation,[150, 151] but the risk significantly increased when alcohol consumption was
> 36 g/day during a follow up of > 50 years in the Framingham Study.[150] Heavy
alcohol consumption was associated with atrial fibrillation in 5% of cases in the
Copenhagen City Heart Study.[152] In a recent meta-analysis of 14 studies, a linear
relationship was found between atrial fibrillation risk and alcohol consumption,
suggesting abstinence from alcohol is most favorable in terms of atrial fibrillation risk
reduction.[153]

Conclusion
Current guidelines recommend limiting alcohol intake to one drink per day for
women, and two drinks per day for men.[154] Existing epidemiological data clearly
demonstrates many favorable biological effects (Figure 3) of light to moderate
alcohol consumption on the cardiovascular system. These include cardioprotective,
anti-inflammatory, anti-oxidant, and hemorheological effects, as well as modulation
of cardiovascular risk factors. A large body of epidemiological data supports the
relationship between light to moderate alcohol consumption and a reduction in
cardiovascular and all-cause mortality; predominantly seen in western populations.
However, a small number of studies did not demonstrate a benefit of light to
moderate alcohol consumption, especially in certain ethnic populations. This may

partly be explained by genetic and metabolic factors, but questions remain
regarding self-reported data collection in some studies and other confounding
factors that may not have been accounted for. Further robust studies are needed in
certain ethnic populations where these benefits could not be replicated.

Cardiovascular benefits of low to moderate alcohol consumption give way to
cardiovascular complications with heavy or binge drinking. These can include
cardiomyopathy and heart failure, hypertension, arrhythmias, and stroke. Routine
recommendations to initiate alcohol consumption to prevent cardiovascular disease
should not be made in the absence of data from randomized controlled trials and the
risk of abuse and addiction. However, in patients at risk for cardiovascular events
who already responsibly consume alcohol, there is little reason to encourage
abstinence.
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Figure Legends
Figure 1: Relationship between total mortality and alcohol intake extracted from 56
curves using fixed- and random-effects models. (With permission from Di
Castelnuovo, A et al. Arch Intern Med, 2006)[8]

Figure 2: Alcohol consumption in relation to cardiovascular mortality in
cardiovascular disease patients. (With permission from Costanzo, S et al. J Am Coll
Cardiol, 2010)[9]

Figure 3: Beneficial mechanisms of light to moderate alcohol consumption

Table 1: Studies showing beneficial effects of light to moderate alcohol consumption
on cardiovascular or all-cause mortality

Table 2: Studies showing neutral effects of light to moderate alcohol consumption on
cardiovascular or all-cause mortality

TABLE 1
Study/Cohort

Participants (n)

Follow-up

All-cause (or) CHD
mortality

Physicians’ Health
Study[155]

89,299

5.5 years

Inverse association

National Health Interview
Survey[12]

245,207

5 years

Inverse association

Framingham Heart
Study[11]

4,745

24 years

U-shaped

German Study[156]

2,084

8 years

U-shaped

British physicians[157]

12,321

13 years

U-shaped

French Study[158]

34,014

10-15 years

U-shaped

Chinese men[159]

18,244

6.7 years

U-shaped

Cancer Prevention Study
II [160]

490,000

9 years

J-, U- or L-shaped

Japanese Study[16]

309,082

12.4 years

J- or U-shaped

Women’s Health
Study[17]

26,399

12.2 years

J-shaped

Women’s Health
Initiative[19]

116,186

8 years

Inverse association

TABLE 2
Study

Cohort

Participants
(n)

Follow-up

All-cause (or)
CHD
mortality

Comment

NHEFS[41]

AfricanAmerican

2,054

19 years

No benefit

None

Hart et al.[42]

Scottish

5,766

21 years

No benefit

Increased
mortality with
> 22 drinks/wk

INTERHEART[43] AsianIndian

4,465

N/A

N/A

No inverse
effect on CHD,
may be harmful

Schooling et al.[45] Chinese

54,090

4.2 years

No benefit

None

Zhou et al.[46]

Chinese

1,476

N/A

No benefit

Moderate to
heavy alcohol
intake was
detrimental for
CHD

Deev et al.[47]

Russian

4,153

13 years

No benefit

None

Strandberg et
al.[48]

Finnish

1,808

29 years

No benefit

Heavy alcohol
intake was
detrimental

Shaper et al.[49]

British

7,169

12.8 years

No benefit

>/= 3 drinks
per day
detrimental

N/A – Not available
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